New scaffold aims to improve breast reconstruction outcomes
NCT ID NCT07480421
First seen Mar 25, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This study will test a new acellular matrix (a supportive scaffold) used with breast implants for immediate breast reconstruction in 100 women born female. The goal is to see if the matrix is safe and helps the body integrate the implant, reducing complications. Participants will be followed for up to 12 months with MRI scans and surveys to assess outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST RECONSTRUCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de câncer HCIII (INCA)
Rio de Janeiro, Rio de Janeiro, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.